Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matloob Ahmad

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory PotentialitiesNoor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 28, 2021
Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazidesZunera Khalid, Sana Aslam, Matloob Ahmad, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|December 27, 2014
Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studiesSumera Zaib, Syed Umar Farooq Rizvi, Sana Aslam, et al.
Pakistan Journal of Pharmaceutical Sciences|February 7, 2020
Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazidesFurqan Ahmad Saddique, Matloob Ahmad, Usman Ali Ashfaq, et al.
IUBMB Life|August 31, 2018
Malic enzyme 2 as a potential therapeutic drug target for cancerIqra Sarfraz, Azhar Rasul, Ghulam Hussain, et al.
European Journal of Medicinal Chemistry|November 12, 2017
Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxidesFurqan Ahmad Saddique, Sumera Zaib, Saquib Jalil, et al.
American Journal of Cancer Research|March 25, 2014
UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporterDongjuan Qiao, Shangjun Tang, Sana Aslam, et al.
Scientific Reports|April 2, 2024
The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approachSaman Taj, Usman Ali Ashfaq, Matloob Ahmad, et al.
Medchemcomm|August 16, 2018
Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, <i>in vitro</i> bioevaluation and molecular docking studiesSyed Mobasher Ali Abid, Sana Aslam, Sumera Zaib, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Synthesis of Novel <i>N</i>-Methylmorpholine-Substituted Benzimidazolium Salts as Potential α-Glucosidase InhibitorsImran Ahmad Khan, Furqan Ahmad Saddique, Sana Aslam, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory PotentialitiesNoor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 28, 2021
Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazidesZunera Khalid, Sana Aslam, Matloob Ahmad, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|December 27, 2014
Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studiesSumera Zaib, Syed Umar Farooq Rizvi, Sana Aslam, et al.
Pakistan Journal of Pharmaceutical Sciences|February 7, 2020
Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazidesFurqan Ahmad Saddique, Matloob Ahmad, Usman Ali Ashfaq, et al.
IUBMB Life|August 31, 2018
Malic enzyme 2 as a potential therapeutic drug target for cancerIqra Sarfraz, Azhar Rasul, Ghulam Hussain, et al.
European Journal of Medicinal Chemistry|November 12, 2017
Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxidesFurqan Ahmad Saddique, Sumera Zaib, Saquib Jalil, et al.
American Journal of Cancer Research|March 25, 2014
UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporterDongjuan Qiao, Shangjun Tang, Sana Aslam, et al.
Scientific Reports|April 2, 2024
The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approachSaman Taj, Usman Ali Ashfaq, Matloob Ahmad, et al.
Medchemcomm|August 16, 2018
Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, <i>in vitro</i> bioevaluation and molecular docking studiesSyed Mobasher Ali Abid, Sana Aslam, Sumera Zaib, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Synthesis of Novel <i>N</i>-Methylmorpholine-Substituted Benzimidazolium Salts as Potential α-Glucosidase InhibitorsImran Ahmad Khan, Furqan Ahmad Saddique, Sana Aslam, et al.
Pageof 10